欧盟资助针对不治之症患者心理困扰的迷幻疗法的研究。 The EU funds research into psychedelic-based therapies for psychological distress in incurable disease patients.

欧盟正在资助基于致幻剂的疗法的研究，以减轻患有不治之症的患者的心理困扰。 The European Union is funding research into psychedelic-based therapies to alleviate psychological distress in patients with incurable diseases. 研究人员将探索使用裸盖菇素等致幻药物来帮助姑息治疗患者，因为这些患者的选择有限。 Researchers will explore the use of psychedelic drugs such as psilocybin to aid palliative care patients, for whom there are limited options. 欧盟对创新治疗方案的投资反映了人们对为绝症患者探索替代疗法的广泛兴趣。 This EU investment in innovative treatment options reflects widespread interest in exploring alternative therapies for those facing terminal illnesses.